| Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis J Li, B Zou, YH Yeo, Y Feng, X Xie, DH Lee, H Fujii, Y Wu, LY Kam, F Ji, ... The lancet Gastroenterology & hepatology 4 (5), 389-398, 2019 | 853 | 2019 |
| Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes J Li, DQ Huang, B Zou, H Yang, WZ Hui, F Rui, NTS Yee, C Liu, ... Journal of medical virology 93 (3), 1449-1458, 2021 | 804 | 2021 |
| Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis Q Ye, B Zou, YH Yeo, J Li, DQ Huang, Y Wu, H Yang, C Liu, LY Kam, ... The lancet Gastroenterology & hepatology 5 (8), 739-752, 2020 | 623 | 2020 |
| 2019 Global NAFLD prevalence: a systematic review and meta-analysis MH Le, YH Yeo, X Li, J Li, B Zou, Y Wu, Q Ye, DQ Huang, C Zhao, ... Clinical Gastroenterology and Hepatology 20 (12), 2809-2817. e28, 2022 | 393 | 2022 |
| Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ... Gastroenterology 156 (3), 635-646. e9, 2019 | 202 | 2019 |
| Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016 B Zou, YH Yeo, VH Nguyen, R Cheung, E Ingelsson, MH Nguyen Journal of internal medicine 288 (1), 139-151, 2020 | 175 | 2020 |
| The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995–2040 T Ito, M Ishigami, B Zou, T Tanaka, H Takahashi, M Kurosaki, M Maeda, ... Hepatology international 15, 366-379, 2021 | 100 | 2021 |
| Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach MH Le, YH Yeo, B Zou, S Barnet, L Henry, R Cheung, MH Nguyen Clinical and molecular hepatology 28 (4), 841, 2022 | 92 | 2022 |
| The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis Y Wu, QI Zheng, B Zou, YH Yeo, X Li, J Li, X Xie, Y Feng, CD Stave, Q Zhu, ... Hepatology international 14, 259-269, 2020 | 74 | 2020 |
| First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis YH Yeo, SI Shiu, HJ Ho, B Zou, JT Lin, MS Wu, JM Liou, CY Wu Gut 67 (1), 20-27, 2018 | 73 | 2018 |
| Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical … F Ji, B Wei, YH Yeo, E Ogawa, B Zou, CD Stave, Z Li, S Dang, N Furusyo, ... Alimentary pharmacology & therapeutics 47 (5), 550-562, 2018 | 65 | 2018 |
| Systematic review with meta‐analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B QI Zheng, B Zou, Y Wu, Y Yeo, H Wu, CD Stave, RC Cheung, MH Nguyen Alimentary Pharmacology & Therapeutics 54 (9), 1100-1109, 2021 | 45 | 2021 |
| NASH/liver fibrosis prevalence and incidence of nonliver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidities: lessons from South Korea J Park, EY Lee, J Li, MJ Jun, E Yoon, SB Ahn, C Liu, H Yang, F Rui, B Zou, ... Digestive Diseases 39 (6), 634-645, 2021 | 41 | 2021 |
| Meta‐analysis: global prevalence, trend and forecasting of non‐alcoholic fatty liver disease in children and adolescents, 2000–2021 J Li, A Ha, F Rui, B Zou, H Yang, Q Xue, X Hu, Y Xu, L Henry, M Barakat, ... Alimentary Pharmacology & Therapeutics 56 (3), 396-406, 2022 | 40 | 2022 |
| Global and regional long‐term survival following resection for HCC in the recent decade: A meta‐analysis of 110 studies RF Reveron‐Thornton, MLP Teng, EY Lee, A Tran, S Vajanaphanich, ... Hepatology Communications 6 (7), 1813-1826, 2022 | 37 | 2022 |
| Fatty liver index and development of cardiovascular disease: findings from the UK Biobank B Zou, YH Yeo, R Cheung, E Ingelsson, MH Nguyen Digestive diseases and sciences 66, 2092-2100, 2021 | 37 | 2021 |
| Statin use and reduced hepatocellular carcinoma risk in patients with nonalcoholic fatty liver disease B Zou, MC Odden, MH Nguyen Clinical Gastroenterology and Hepatology 21 (2), 435-444. e6, 2023 | 36 | 2023 |
| A nationwide study of inpatient admissions, mortality, and costs for patients with cirrhosis from 2005 to 2015 in the USA B Zou, YH Yeo, D Jeong, H Park, E Sheen, DH Lee, L Henry, G Garcia, ... Digestive diseases and sciences 65, 1520-1528, 2020 | 30 | 2020 |
| Prevalence of viremic hepatitis C virus infection by age, race/ethnicity, and birthplace and disease awareness among viremic persons in the United States, 1999–2016 B Zou, YH Yeo, MH Le, L Henry, ET Chang, AS Lok, R Cheung, ... The Journal of infectious diseases 221 (3), 408-418, 2020 | 30 | 2020 |
| ALT levels for Asians with metabolic diseases: a meta‐analysis of 86 studies with individual patient data validation DQ Huang, YH Yeo, E Tan, H Takahashi, S Yasuda, J Saruwatari, ... Hepatology Communications 4 (11), 1624-1636, 2020 | 23 | 2020 |
